Published in Ned Tijdschr Geneeskd on May 27, 1995
[Diagnosis of lymph node metastasis of head-neck carcinomas]. Ned Tijdschr Geneeskd (1995) 0.75
Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med (2007) 4.72
Oral metastases: report of 24 cases. Br J Oral Maxillofac Surg (2003) 4.40
Cervical lymph node metastasis: assessment of radiologic criteria. Radiology (1990) 3.24
Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients. Neurology (2007) 2.88
Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol (1999) 2.61
The size of lymph nodes in the neck on sonograms as a radiologic criterion for metastasis: how reliable is it? AJNR Am J Neuroradiol (1998) 2.48
Oral white lesions with special reference to precancerous and tobacco- related lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18-21 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med (1996) 2.29
The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncol (2006) 2.18
A review of the recent literature regarding malignant transformation of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1999) 2.12
Regional DTI differences in multiple sclerosis patients. Neuroimage (2008) 2.03
Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer (1995) 2.00
Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer (1994) 1.98
Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications. J Oral Pathol Med (2003) 1.92
Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol (1998) 1.82
Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer (1993) 1.82
Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer (2001) 1.82
Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes. J Natl Cancer Inst (1999) 1.68
Prognostic factors of neck node metastasis. Clin Otolaryngol Allied Sci (1982) 1.67
Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology (2004) 1.65
Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res (2001) 1.60
The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer (1999) 1.53
Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain (1998) 1.52
Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck. J Nucl Med (2000) 1.52
The human E48 antigen, highly homologous to the murine Ly-6 antigen ThB, is a GPI-anchored molecule apparently involved in keratinocyte cell-cell adhesion. J Cell Biol (1995) 1.51
Effect of ice compression on pain after mandibular third molar surgery: a single-blind, randomized controlled trial. Int J Oral Maxillofac Surg (2008) 1.47
The effect of calcium on the secretion of factor VIII-related antigen by cultured human endothelial cells. Biochim Biophys Acta (1983) 1.45
Screening for distant metastases in patients with head and neck cancer. Laryngoscope (2000) 1.42
Potential early markers of carcinogenesis in the mucosa of the head and neck using exfoliative cytology. J Pathol (1996) 1.42
MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter. Magn Reson Med (2005) 1.42
Characteristics of 40 primary extranodal non-Hodgkin lymphomas of the oral cavity in perspective of the new WHO classification and the International Prognostic Index. Int J Oral Maxillofac Surg (2005) 1.41
Oral findings in HIV-infected patients attending a department of internal medicine: the contribution of intraoral examination towards the clinical management of HIV disease. Q J Med (1990) 1.41
Trigeminal neuralgia: comparison of two MR imaging techniques in the demonstration of neurovascular contact. Radiology (1997) 1.40
[Development and results of surgical treatment of pleomorphic adenoma of the parotid gland in 245 patients, 1974-1994]. Ned Tijdschr Geneeskd (1996) 1.39
Total glossectomy with laryngeal preservation. Arch Otolaryngol Head Neck Surg (1993) 1.38
Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol (1993) 1.37
Interobserver variability in the radiological assessment of response to chemotherapy in glioma. Neurology (2003) 1.35
Primary extranodal non-Hodgkin lymphoma of the oral cavity. An analysis of 34 cases. Eur J Cancer B Oral Oncol (1994) 1.31
Metastasizing ameloblastoma. Int J Oral Maxillofac Surg (2007) 1.31
The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up. Eur J Cancer (2001) 1.31
Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol (1998) 1.30
Oral lipomas with osseous and chondrous metaplasia; report of two cases. J Oral Pathol (1982) 1.28
Accumulation of cortical lesions in MS: relation with cognitive impairment. Mult Scler (2009) 1.27
Post-mortem high-resolution MRI of the spinal cord in multiple sclerosis: a correlative study with conventional MRI, histopathology and clinical phenotype. Brain (2001) 1.25
Lack of lymphangiogenesis during breast carcinogenesis. J Clin Pathol (2004) 1.25
Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology. Int J Cancer (1992) 1.24
Surgical management of 246 previously untreated pleomorphic adenomas of the parotid gland. Br J Surg (1997) 1.22
Standardization of counting micronuclei: definition of a protocol to measure genotoxic damage in human exfoliated cells. Carcinogenesis (1995) 1.21
Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer. J Clin Pathol (1995) 1.21
Neuronal damage in T1-hypointense multiple sclerosis lesions demonstrated in vivo using proton magnetic resonance spectroscopy. Ann Neurol (1999) 1.20
Targeting of aluminum (III) phthalocyanine tetrasulfonate by use of internalizing monoclonal antibodies: improved efficacy in photodynamic therapy. Cancer Res (2001) 1.19
Lymph node staging in patients with clinically negative neck examinations by ultrasound and ultrasound-guided aspiration cytology. Am J Surg (1991) 1.18
Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions. Neurology (2002) 1.18
p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol (1998) 1.18
The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope (1996) 1.16
Detection of factor VIII/coagulant antigen in human liver tissue. Nature (1983) 1.16
Parapharyngeal tumours: a review of 23 cases. Clin Otolaryngol Allied Sci (1989) 1.15
Delay in diagnosis of oral squamous cell carcinoma; a report from The Netherlands. Eur J Cancer B Oral Oncol (1992) 1.14
Squamous cell carcinoma of maxillary sinus. Head Neck (2000) 1.14
Development of meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy. Cancer Res (1999) 1.14
Nasopalatine duct cyst. Review of the literature and report of 22 cases. Int J Oral Surg (1981) 1.13
False-positive and false-negative neck nodes. Head Neck Surg (1986) 1.13
Cheilitis granulomatosa. J Eur Acad Dermatol Venereol (2001) 1.11
Effect of chemotherapy on survival of craniofacial osteosarcoma: a systematic review of 201 patients. J Clin Oncol (1997) 1.11
Labeling of monoclonal antibodies with rhenium-186 using the MAG3 chelate for radioimmunotherapy of cancer: a technical protocol. J Nucl Med (1993) 1.10
Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg (1995) 1.09
Von Willebrand factor in the vessel wall mediates platelet adherence. Blood (1985) 1.09
Age-dependence of human papillomavirus DNA presence in oral squamous cell carcinomas. Eur J Cancer B Oral Oncol (1996) 1.08
Assessment of malnutrition parameters in head and neck cancer and their relation to postoperative complications. Head Neck (1997) 1.08
Histological reclassification of 101 intraoral salivary gland tumours (new WHO classification). J Clin Pathol (1992) 1.08
Oral leukoplakia, with emphasis on malignant transformation. A follow-up study of 46 patients. J Craniomaxillofac Surg (1989) 1.07
Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: a phase II study of the EORTC Head and Neck Cancer Cooperative Group. Ann Oncol (1993) 1.07
The surgical management of recurrent or residual pleomorphic adenomas of the parotid gland. Analysis and results in 40 patients. Eur Arch Otorhinolaryngol (1997) 1.06